CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.92 +0.02 (+2.22%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Amortizatization of Intangibles (2023 - 2025)

Updated

CytoMed Therapeutics' Amortizatization of Intangibles came in at $30,542 for FY2025, up 131.4% from $13,199 in FY2024.

Analysis

CytoMed Therapeutics (GDTC) Amortizatization of Intangibles (2023 - 2025) Analysis & Trends

Going back to FY2020, CytoMed Therapeutics' Amortizatization of Intangibles data covers 6 years.

  • Amortizatization of Intangibles carries a five-year compound annual growth rate of 22.2% (FY2020 to FY2025).
  • The FY2025 figure represents the highest annual Amortizatization of Intangibles in data going back to FY2020.
  • Per Business Quant, earlier years put Amortizatization of Intangibles at $13,199 in FY2024 (+106.4%), $6,396 in FY2023 (-51.5%), $13,200 in FY2022 (-0.1%) and $13,212 in FY2021 (+17.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 600.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 CytoMed Therapeutics 10.88 Mn -200,496.58 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 321.00
Jun 30, 2024 321.00
Jun 30, 2023 3,887.00
API Access

CytoMed Therapeutics Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=GDTC&period=max&api_key=YOUR_API_KEY